Comorbidity Increases the Risk of Invasive Meningococcal Disease in Adults

被引:8
作者
Lundbo, Lene Fogt [1 ]
Harboe, Zitta Barrella [2 ,3 ,4 ]
Sandholdt, Hakon [1 ]
Smith-Hansen, Lars [5 ]
Valentiner-Branth, Palle [6 ]
Hoffmann, Steen [7 ]
Benfield, Thomas [1 ,4 ]
机构
[1] Copenhagen Univ Hosp Amager & Hvidovre, Ctr Res & Disrupt Infect Dis, Dept Infect Dis, Hvidovre, Denmark
[2] Copenhagen Univ Hosp North Zealand, Dept Pulm & Infect Dis, Copenhagen, Denmark
[3] Statens Serum Inst, Dept Microbiol Surveillance & Res, Copenhagen, Denmark
[4] Univ Copenhagen, Fac Hlth Sci, Dept Clin Med, Copenhagen, Denmark
[5] Copenhagen Univ Hosp Amager & Hvidovre, Dept Clin Res, Hvidovre, Denmark
[6] Statens Serum Inst, Dept Infect Dis Epidemiol & Prevent, Infect Dis Preparedness, Copenhagen, Denmark
[7] Statens Serum Inst, Dept Bacteria Parasites & Fungi, Infect Dis Preparedness, Copenhagen, Denmark
关键词
Neisseria meningitidis; sepsis; meningitis; comorbidity; IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; ASPLENIC PATIENTS; INFECTIONS; PREVENTION; RECOMMENDATIONS; IMMUNOGENICITY; VACCINES;
D O I
10.1093/cid/ciab856
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this Danish case-control-study that included >1200 cases over 4 decades, certain comorbidities increased risk of invasive meningococcal disease, ranging from a 2- to 40-fold increased risk. Vaccination and increased focus on appropriate medical care may be warranted in these populations. Background Risk of invasive meningococcal disease (IMD) is increased in patients with complement deficiency and human immunodeficiency virus (HIV) infection. Risk associated with comorbidity is not well described. Methods This was a nationwide adult case-control study. Cases for the period 1977-2018 were identified by the national meningococcus reference laboratory. Matched controls were identified by registry linkage. Comorbidities diagnosed prior to IMD were based on the International Classification of Diseases, Eighth or Tenth Revision. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated by logistic regression after adjustment for sex, age, and other comorbidities. Results We identified 1221 cases (45% male), with a median age of 45 years (interquartile range, 22-64 years). The dominant meningococcal serogroups were B (n = 738) and C (n = 337). Increased risk of IMD was associated with solid organ transplantation (SOT) (OR 40.47 [95% CI: 4.84-337.23]), hemolytic anemia (OR 7.56 [95% CI: 2.63-21.79]), renal disease (OR 2.95 [95% CI: 1.77-4.92]), liver disease (OR 2.54 [95% CI: 1.58-4.08]), cancer (OR 2.31 [95% CI: 1.85-2.89]), diabetes (OR 1.74 [95% CI: 1.27-2.39]), neurological disease (OR 1.72 [95% CI: 1.20-2.46]), and autoimmune disease (OR 1.70 [95% CI: 1.63-2.11]). Having 1, 2, and >= 3 comorbidities was associated with increased risk of IMD (ORs 1.6-3.5). Increased risk was not associated with specific serogroups. Conclusions This study of adults with IMD over 4 decades showed increased risk of IMD associated with renal disease, immunological disorders, liver disease, cancer, and SOT ranging from a 2- to 40-fold increased risk. Vaccination may be warranted in these populations.
引用
收藏
页码:125 / 130
页数:6
相关论文
共 50 条
[41]   Control of invasive meningococcal disease: is it achievable? [J].
Marshall, Helen ;
Wang, Bing ;
Wesselingh, Steve ;
Snape, Matthew ;
Pollard, Andrew J. .
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE, 2016, 14 (01) :3-14
[42]   Invasive meningococcal disease and genome databases [J].
Karlsson, Jens ;
Eichner, Hannes ;
Loh, Edmund .
LANCET MICROBE, 2021, 2 (09) :E421-E422
[43]   Underestimation of Invasive Meningococcal Disease in Italy [J].
Azzari, Chiara ;
Nieddu, Francesco ;
Moriondo, Maria ;
Indolfi, Giuseppe ;
Canessa, Clementina ;
Ricci, Silvia ;
Bianchi, Leila ;
Serranti, Daniele ;
Poggi, Giovanni Maria ;
Resti, Massimo .
EMERGING INFECTIOUS DISEASES, 2016, 22 (03) :469-475
[44]   Bivalent rLP2086 Vaccine (Trumenba®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10-25 Years [J].
Shirley, Matt ;
Dhillon, Sohita .
BIODRUGS, 2015, 29 (05) :353-361
[45]   Respiratory Virus Infection and Risk of Invasive Meningococcal Disease in Central Ontario, Canada [J].
Tuite, Ashleigh R. ;
Kinlin, Laura M. ;
Kuster, Stefan P. ;
Jamieson, Frances ;
Kwong, Jeffrey C. ;
McGeer, Allison ;
Fisman, David N. .
PLOS ONE, 2010, 5 (11)
[46]   Outcomes of adults with invasive meningococcal disease with reduced penicillin susceptibility in Auckland 2004–2017 [J].
Matthew Broom ;
Emma Best ;
Helen Heffernan ;
Sara Svensson ;
Maria Hansen Hygstedt ;
Rachel Webb ;
Nick Gow ;
David Holland ;
Mark Thomas ;
Simon Briggs .
Infection, 2023, 51 :425-432
[47]   Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adults [J].
Nolan, Terry ;
O'Ryan, Miguel ;
Wassil, James ;
Abitbol, Veronique ;
Dull, Peter .
VACCINE, 2015, 33 (36) :4437-4445
[48]   Recent increased incidence of invasive serogroup W meningococcal disease: A retrospective observational study [J].
Hovmand, Nichlas ;
Lundbo, Lene Fogt ;
Kronborg, Gitte ;
Voss, Sidsel Skou ;
Sandholdt, Hakon ;
Hoffmann, Steen ;
Valentiner-Branth, Palle ;
Ben, Thomas .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 108 :582-587
[49]   US College Students Are at Increased Risk for Serogroup B Meningococcal Disease [J].
Marshall, Gary S. ;
Dempsey, Amanda F. ;
Srivastava, Amit ;
Isturiz, Raul E. .
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2020, 9 (02) :244-247
[50]   Geographical distribution of invasive meningococcal disease and carriage: A spatial analysis [J].
Milazzo, Adriana ;
Mcmillan, Mark ;
Giles, Lynne ;
Page, Kira ;
Flood, Louise ;
Marshall, Helen .
EPIDEMIOLOGY & INFECTION, 2024, 152